ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 198,37
-0,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) Actualités

TNXP Tonix Pharmaceuticals Holding Corporation

0,1711
-0,0034 (-1,95%)
25 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0034 -1,95% 0,1711 01:43:45
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,18 0,1601 0,1859 0,1755 0,1745
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/5/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202423:16EDGAR2Form 8-K - Current report
22/5/202414:05EDGAR2Form 8-K - Current report
22/5/202414:00GLOBETonix Pharmaceuticals to Deliver an Oral Presentation and..
21/5/202414:07EDGAR2Form 8-K - Current report
21/5/202414:00GLOBETonix Pharmaceuticals Announces Key Findings from Initial..
15/5/202414:00GLOBETonix Pharmaceuticals to Present at the Alliance Global..
13/5/202422:56EDGAR2Form 8-K - Current report
13/5/202422:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:30GLOBETonix Pharmaceuticals Reports First Quarter 2024 Financial..
24/4/202414:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
01/4/202422:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
28/3/202414:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/3/202413:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/3/202413:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/3/202413:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/3/202413:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/3/202413:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/3/202413:05EDGAR2Form 8-K - Current report
11/3/202413:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
07/3/202415:37GLOBENew to The Street Announces TV Episode 560 with its Five..
07/3/202414:06EDGAR2Form 8-K - Current report
07/3/202414:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
06/3/202423:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/3/202414:05EDGAR2Form 8-K - Current report
06/3/202414:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
05/3/202414:05EDGAR2Form 8-K - Current report
05/3/202414:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
29/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
28/2/202414:06EDGAR2Form 8-K - Current report
28/2/202414:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
27/2/202414:07EDGAR2Form 8-K - Current report
27/2/202414:00GLOBETonix Pharmaceuticals Announces Positive Results from..
23/2/202415:30GLOBENew to The Street Announces Line-up of its Corporate..
20/2/202414:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
16/2/202415:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
15/2/202423:02EDGAR2Form 8-K - Current report
14/2/202421:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
13/2/202414:05EDGAR2Form 8-K - Current report
13/2/202414:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
12/2/202414:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
12/2/202413:06EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
TNXP
Tonix Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés